IFNG and celiac disease: In celiac disease, gliadin peptides activate CD4+ T cells, triggering release of pro‐inflammatory cytokines (TNF‐α, IFN‐γ, IL‐8) that parallel the cytokine cascade seen in PRES‐associated conditions [20].